Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer-Vitiva partnership

This article was originally published in The Tan Sheet

Executive Summary

Bayer Pharmaceuticals and Vitiva have signed an agreement to develop exclusive isolation of esters from marigold flowers, the firms announce July 5. The initiatve is related to Bayer's registered patent for a natural OTC product based on marigold flower extract, a press release adds. The partnership will "stimulate development of innovative products and will deliver new solutions for consumers who prefer to use natural ingredients," Vitiva says. Bayer Pharmaceuticals is part of the new Global Pharmaceutical Division that was established Jan. 1 and grew out of the former Biological Products and Pharmaceutical Division...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS099532

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel